Key result
The optimal target blood pressure for elderly hypertensive patients remains controversial, requiring individualized treatment strategies that account for multimorbidity, frailty, and cognitive function.
Why the study?
The optimal target blood pressure for older patients with hypertension has been debated, with previous clinical trials providing conflicting evidence.
Does individualized intensive blood pressure control reduce cardiovascular events in elderly patients with hypertension?
Does individualized intensive blood pressure control reduce cardiovascular events in elderly patients with hypertension?
Management of hypertension in elderly patients requires individualized blood pressure targets that account for frailty, multimorbidity, and the risk of adverse events.
Caution advised when setting BP targets in frail elderly hypertensives; leaves open optimal individualized thresholds pending frailty-stratified RCTs.
Hypertension is a common condition among older adults, and blood pressure (BP) control is effective for preventing cardiovascular morbidity and mortality even among the oldest-old adults. However, the optimal target BP for older patients with hypertension has been a subject of debate, with previous clinical trials providing conflicting evidence. Determining the optimal target BP for older adults is a complex issue that requires considering comorbidities, frailty, quality of life, and goals of care. As such, BP targets should be individualized based on each patient's unique health status and risk factors, and treatment should be closely monitored to ensure that it is effective and well-tolerated. The benefits and risks of intensive BP control should be carefully weighed in the context of the patient's overall health status and treatment goals. Ultimately, the decision to pursue intensive BP control should be made through shared decision-making between patients and their healthcare providers.
No takes yet. Share an insight, caveat, or question.
Kwang‐Il Kim (2023) conducted a review in Hypertension. Antihypertensive therapy was evaluated. The optimal target blood pressure for elderly hypertensive patients remains controversial, requiring individualized treatment strategies that account for multimorbidity, frailty, and cognitive function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: